Skip to main content

Market Overview

Morgan Stanley Sees Brighter View On 2016 Emerging For Stryker


In a report published Friday, Morgan Stanley analyst David R. Lewis reiterated an Overweight rating and $105.00 price target on Stryker Corporation (NYSE: SYK).

In the report, Morgan Stanley noted, "Our discussions with management at AAOS struck a bullish tone and pointed to an inflection coming over the next 12 months. We see opportunities to (i) gain share in Europe, specifically in MedSurg, (ii) drive Mako adoption following recent momentum and approvals, (iii) grow sports med and extremities through recent product additions,and (iv) build on emerging market progress through Trauson geographic expansion. Additionally, Stryker's balance sheet remains a flexible growth driver even as the SNN debate fades."

Stryker closed on Thursday at $91.53.

Latest Ratings for SYK

Apr 2021Canaccord GenuityMaintainsBuy
Apr 2021Morgan StanleyMaintainsOverweight
Apr 2021Wells FargoMaintainsOverweight

View More Analyst Ratings for SYK
View the Latest Analyst Ratings


Related Articles (SYK)

View Comments and Join the Discussion!

Posted-In: David R. Lewis Morgan StanleyAnalyst Color Reiteration Analyst Ratings

Latest Ratings

NKLADeutsche BankMaintains16.0
SHAKDeutsche BankMaintains95.0
ESNTDeutsche BankMaintains62.0
APTVDeutsche BankMaintains165.0
ATVIDeutsche BankMaintains118.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at